Bio Rad Laboratories Inc

US

BIO

Health Care

280.13 ₽

Current price

Sell
280.13 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    139 / 240

  • Position in country

    10174 / 14179

  • Return on Assets, %

    -4.8

    -2.7

  • Net income margin, %

    51.3

    -6.7

  • EBITDA margin, %

    20.3

    5.6

  • Debt to Equity, %

    13.7

    15.1

  • Intangible assets and goodwill, %

    5.9

    4.7

  • Revenue CAGR 3Y, %

    1.6

    12.8

  • Total Equity change 1Y, %

    -9.1

    -2.4

  • Revenue Y, % chg

    -4.7

    0

  • P/BV

    0.9

    2

  • P/S

    3.7

    4.1

  • EV/S

    3.7

    3.6

  • EV/EBITDA

    19.1

    7.8

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    39.7

    48.9

  • Forward P/E

    27.4

    25.5

  • Expected dividend per share

    0

    0

Get an analytical review of this company

Competitors

Ranks

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Bio Rad Laboratories Inc

    00%

  • Mettler-Toledo International Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    10293.5

  • Ticker

    BIO.N

  • ISIN

    US0905722072

  • IPO date

    1980-03-17

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-16

  • Date fact. publication of reports

    2023-12-31

Company Description

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.